HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ABT-870

an iron (III)-hydroxide oligosaccharide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Iron Compounds: 87
  - Ferric Compounds: 6
    - ABT-870: 1
Carbohydrates: 22023
- Polysaccharides: 15383
  - Oligosaccharides: 3566
    - ABT-870: 1

Experts

1.	Cox, Bryan F: 1 article (12/2005)
2.	Delgado-Herrera, Leticia: 1 article (12/2005)
3.	Fryer, Ryan M: 1 article (12/2005)
4.	Gerhardt, Armin: 1 article (12/2005)
5.	Hu, Yanhui: 1 article (12/2005)
6.	Melnick, Joel Z: 1 article (12/2005)
7.	Preusser, Lee C: 1 article (12/2005)
8.	Reinhart, Glenn A: 1 article (12/2005)
9.	Williams, Laura A: 1 article (12/2005)

Related Diseases

1.

Hypotension (Low Blood Pressure)

12/01/2005 - "Sodium ferric gluconate complex (SFGC) was administered in an identical fashion at doses of 12.5 and 31.2 mg/kg. A 30 s rapid infusion of ABT-870 at doses of 7.1 and 14.3 mg/kg or a 10 min infusion of ABT-870 at doses of 7.1 and 21.3 mg/kg produced little effect on MAP and HR. Infusion of the highest dose of ABT-870 (50 mg/kg) produced no consistent hypotension, but did produce an increase in HR (maximal increase 35 +/- 9 b.p.m.), an effect that lasted only 15 min. A 30 s rapid infusion of iron sucrose at 7.1 mg/kg produced modest increases in MAP and HR (5 +/- 1 mmHg and 5 +/- 2 b.p.m., respectively). "

Related Drugs and Biologics

1.	Sodium
2.	Saccharated Ferric Oxide (Venofer)
3.	antineoplaston A10 (A 10)
4.	ferric gluconate (Ferrlecit)